Reviewing the draft NHS commercial medicines framework – clarification made possible through collaboration and dialogue

The draft NHS Commercial Framework for Medicines is published and out for consultation. The Framework was a commitment set out in the recent

logo
Joe Cormack 21st Nov, 2019 Insight
Health , NHS , Healthcare
3 min read

What we’ve learned from Labour conference

It’s safe to say this was a Labour party conference unlike any other, with more disruption and changes of schedule than a Southern rail service. Amidst the confusion and grumblings over the party’s Brexit position though, there was debate, innovative policies and a positivity that Labour will have a transformative manifesto capable of winning the next election. GK were on the ground at conference and our key takeaways from the South Coast are: The mood in the party is as...

Private Equity investment in Pharma – why is the UK bucking the global trend?

In recent years we’ve become used to claims that the impasse of Brexit is drying up investment in UK life sciences. The argument also goes that global investment by pharmaceuticals in R&D – predicted to grow to $181 billion by 2022 – will instead flow to other countries. There is evidence that can support this theory but if you scrape below the surface and look at investment by private equity into life sciences the picture looks quite different. The figures actually suggest that...

logo
Joe Cormack 25th Sep, 2019 Insight
Brexit , Healthcare , Investment , pharma
5 min read

How to support improved patient safety within the NHS

The NHS’s Long-term plan set out the aspiration to become the safest health service worldwide and more transparent in its operations across physical and mental health. With approximately one million patients being treated every 36 hours, it is essential that the NHS’ systems, skills and culture are tailored and optimised to ensure the prospect of error is minimised. To put the situation into perspective, recent studies suggest that 237 million medication errors occur in the NHS every...

logo
Joe Cormack 23rd Apr, 2019 Insight 5 min read

Using Parliamentary Select Committees to shape policy and raise profile

Since the UK’s decision to leave the EU, businesses, trade associations and the third sector have experienced a sustained period of uncertainty. It is not just the Groundhog Day feeling generated by the process that is frustrating, but the lack of a domestic agenda in Parliament. The legislative process has noticeably slowed. A combination of Brexit and a minority Conservative Government has made any prospect of initiating transformative change in crucial areas such as health and education...

logo
Joe Cormack 6th Feb, 2019 Insight
Brexit , Select Committee , Politics
3 min read

Private providers – making the case for public services reform

The last decade has seen the most protracted squeeze on public services spending for a generation. This has created a paradox where public sector organisations have less resources and “headroom” to undertake reform. However, simultaneously, they have a pressing need for transformation to trim spending. “Doing more with less” is something councils are well familiar with. There has been an estimated 40% cut in budgets since 2010. The challenges in this context do outweigh the...

logo
Joe Cormack 28th Aug, 2018 Strategy , Impact

Making the Life Sciences Industrial Strategy A Success

GK Strategy was pleased to host Lord Henley, Parliamentary-under-Secretary of State at the Department for Business, Energy and Industrial Strategy (BEIS), and Louisa Elias-Evans, from the Office for Life Sciences (OLS), to discuss the Government’s plans to make the Life Sciences Industrial Strategy a success. The roundtable discussion explored the progress of the Life Sciences Sector Deal and looked ahead to how other recommendations and themes contained within the industry-led Life...

logo
Joe Cormack 26th Jun, 2018 Insight 3 min read